Genomic medicines can cost $3m a dose. How to make them affordable
The treatments are marvels of innovation. Their pricing must be inventive, too
Many diseases are the result of choice or circumstance: an unhealthy way of life, toxic living conditions or a chance encounter with a virus or bacterium. Others are predestined—because they are written in the genes. Millions of people worldwide suffer from the most common genetic diseases, such as sickle-cell anaemia or thalassemia, two blood disorders. A long tail of rarer conditions each afflict an unfortunate few, who add up to many millions in total.
Leaders August 3rd 2024
- Chinese companies are winning the global south
- The Middle East must step back from the brink
- Genomic medicines can cost $3m a dose. How to make them affordable
- Can Nicolás Maduro be stopped from stealing Venezuela’s election?
- Is the big state back in Britain?
- How to make tourism work for locals and visitors alike
From the August 3rd 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Leaders
How to improve clinical trials
Involving more participants can lead to new medical insights
Houthi Inc: the pirates who weaponised globalisation
Their Red Sea protection racket is a disturbing glimpse into an anarchic world
Donald Trump will upend 80 years of American foreign policy
A superpower’s approach to the world is about to be turned on its head
Rising bond yields should spur governments to go for growth
The bond sell-off may partly reflect America’s productivity boom
Much of the damage from the LA fires could have been averted
The lesson of the tragedy is that better incentives will keep people safe
Health warnings about alcohol give only half the story
Enjoyment matters as well as risk